Categories: Wire Stories

XPENG to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Friday, March 17, 2023

– Earnings Call Scheduled for 8:00 a.m. ET on March 17, 2023

GUANGZHOU, China–(BUSINESS WIRE)–$XPEV #EV–XPeng Inc. (�XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced that it will report its fourth quarter and fiscal year 2022 unaudited financial results on Friday, March 17, 2023, before the open of U.S. markets.

The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 17, 2023 (8:00 PM Beijing/Hong Kong time on March 17, 2023).

For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the scheduled call start time. Upon registration, each participant will receive dial-in details to join the conference call.

Event Title:

XPeng Inc. Fourth Quarter 2022 Earnings Conference Call

Pre-registration link:

https://s1.c-conf.com/diamondpass/10028722-ty785x.html

Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at http://ir.xiaopeng.com.

A replay of the conference call will be accessible approximately an hour after the conclusion of the call until March 24, 2023, by dialing the following telephone numbers:

United States:

+1-855-883-1031

International:

+61-7-3107-6325

Hong Kong, China:

800-930-639

China Mainland:

400-120-9216

Replay PIN:

10028722

About XPeng Inc.

XPeng Inc. (“XPENG”) is a leading Chinese Smart EV company that designs, develops, manufactures, and markets smart EVs that appeal to the large and growing base of technology-savvy middle-class consumers. Its mission is to drive Smart EV transformation with technology and data, shaping the mobility experience of the future. In order to optimize its customers’ mobility experience, XPENG develops in-house its full-stack advanced driver-assistance system technology and in-car intelligent operating system, as well as core vehicle systems including powertrain and the electrical/electronic architecture. XPENG is headquartered in Guangzhou, China, with main offices in Beijing, Shanghai, Silicon Valley, San Diego and Amsterdam. The Company’s Smart EVs are mainly manufactured at its plant in Zhaoqing, Guangdong province. For more information, please visit https://heyXPENG.com.

Contacts

For Investor Enquiries:

IR Department

XPeng Inc.

E-mail: ir@xiaopeng.com

Jenny Cai

The Piacente Group

Tel: +1-212-481-2050 or +86-10-6508-0677

E-mail: xpeng@tpg-ir.com

For Media Enquiries:

PR Department

XPeng Inc.

E-mail: pr@xiaopeng.com

Alex

Recent Posts

Capstone Copper Announces 2024 Annual General and Special Meeting Results

VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…

16 hours ago

Indonesia International Remittance Market Growth and Future Opportunities 2024-2028: Rising Transaction Values and Volumes Characterize the Landscape – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…

16 hours ago

KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance

KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…

22 hours ago

Firstsource Acquires Quintessence

Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…

23 hours ago

UPCX Becomes the Main Sponsor for Coinfest Asia 2024

SINGAPORE - Media OutReach Newswire - 3 May 2024 - UPCX (UPC), a developer of…

23 hours ago

China Biological Reagents (Molecular Biology Reagents, Proteins and Cell Reagents) Industry Research 2023-2024 & 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights &…

24 hours ago